Skip to main content
xMedica

Search

164 studies match these filters. Showing 51–75 of 164 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07284979Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to semaglutide SC once weekly and to placebo SC once weekly on percent change in body weight.

Contact Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 59 sites in total

RecruitingPhase 31,200target59 / 52025Sep 1, 2026
NCT07564414A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive eith…

Contact Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 303 sites in total

RecruitingPhase 32,500target303 / 192026Aug 31, 2026
NCT07662044A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with other background glucos…

Contact Claimed

Nearest site: Newton, Kansas, United States — 53 km away · 149 sites in total

RecruitingPhase 3800target149 / 132026Aug 31, 2026
NCT06319820A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 193 sites in total

RecruitingPhase 3641target193 / 202024Aug 28, 2026
NCT06662786A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folini…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 239 sites in total

RecruitingPhase 31,000target239 / 222024Aug 28, 2026
NCT06750094A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovor…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 251 sites in total

RecruitingPhase 3700target251 / 262024Aug 28, 2026
NCT07196722A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 370 sites in total

RecruitingPhase 2 / Phase 31,092target370 / 282025Aug 28, 2026
NCT07225946A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxe…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 152 sites in total

RecruitingPhase 3800target152 / 172025Aug 28, 2026
NCT07674654A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total

RecruitingPhase 31,000target113 / 12026Aug 27, 2026
NCT06059638BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 131 sites in total

RecruitingNot applicable316target131 / 152023Aug 26, 2026
NCT06742723A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure

Contact Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 771 sites in total

RecruitingPhase 35,000target771 / 422025Aug 26, 2026
NCT06283966A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 921 sites in total

RecruitingPhase 35,000target921 / 372024Aug 26, 2026
NCT05102019Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coro…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 96 sites in total

RecruitingNot applicable380target96 / 32022Aug 26, 2026
NCT07226791Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

A ventral hernia happens when the muscles in the front of your belly become weak and let organs push through, causing a bulge. If it gets worse, intestines can slip into the bulge, leading to serious pain and health problems. This study aims to asses if AGN-151607-DP is safe and effective for closin…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 13 sites in total

RecruitingPhase 2200target13 / 12026Aug 25, 2026
NCT07466316A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

This phase III trial compares higher dose chemotherapy, with vincristine, dactinomycin and cyclophosphamide, over a shorter amount of time to lower dose chemotherapy plus maintenance, with vincristine, dactinomycin, cyclophosphamide, irinotecan and vinorelbine, over a longer amount of time, along wi…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 87 sites in total · contact listed

RecruitingPhase 3342target87 / 22026Aug 25, 2026
NCT05677100Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejec…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 50 sites in total

RecruitingNot applicable320target50 / 22023Aug 25, 2026
NCT07000357A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in patients with established ASCVD or at high risk for a first ASCVD event. The effect of AZD0780 vs pl…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 1,452 sites in total

RecruitingPhase 315,100target1,452 / 362025Aug 24, 2026
NCT06424288A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empag…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 652 sites in total · contact listed

RecruitingPhase 36,000target652 / 302024Aug 21, 2026
NCT07136012OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).

Contact Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 252 sites in total

RecruitingPhase 311,000target252 / 32025Aug 21, 2026
NCT07645924A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 113 sites in total · contact listed

RecruitingPhase 31,800target113 / 12026Aug 20, 2026
NCT07415031A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorect…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 100 sites in total · contact listed

RecruitingPhase 2170target100 / 202026Aug 18, 2026
NCT07097142Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

This phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with standard of care chemotherapy, with cisplatin, gemcitabine or mitomycin and 5-fluorouracil for the treatment of patients…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 211 sites in total · contact listed

RecruitingPhase 3486target211 / 12025Aug 18, 2026
NCT07567001A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to fi…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 838 sites in total

RecruitingPhase 35,610target838 / 272026Aug 18, 2026
NCT05624996Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy \[IGRT\] and chemotherapy followed by immunotherapy with durvalumab or targeted therapy with osimertinib) versus the usual treatment alone…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 477 sites in total · contact listed

RecruitingPhase 3474target477 / 22023Aug 17, 2026
NCT07764978Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of standard induction regimens (IsaVRd and DRd) followed by AZD0120 versus standard induction regimens followed by continuous therapy (IsaRd and DRd) in participants with newly diagnos…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 124 sites in total

RecruitingPhase 3750target124 / 152026Aug 14, 2026

Filters

Clear all filters